Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)

K. R. Cullen; P. Amatya; Mark G Roback; C. S. Albott; M. Westlund Schreiner; Yanan Ren; L. E. Eberly; P. Carstedt; A. Samikoglu; M. Gunlicks-Stoessel; K. Reigstad; N. Horek; Susannah J Tye; Kelvin O Lim; B. Klimes-Dougan

doi:10.1089/cap.2018.0030.correx

Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)

K. R. Cullen
, P. Amatya
, Mark G Roback
, C. S. Albott
, M. Westlund Schreiner
, Yanan Ren
, L. E. Eberly
, P. Carstedt
, A. Samikoglu
, M. Gunlicks-Stoessel
, K. Reigstad
, N. Horek
, Susannah J Tye
, Kelvin O Lim
, B. Klimes-Dougan

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the September 2018 issue of Journal of Child and Adolescent Psychopharmacology (vol. 28, no. 7, pp. 437-444), the article "Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study," by Dr. Kathryn R. Cullen et al., was missing the financial support information as follows: This research was supported by the National Institutes of Health's National Center for Advancing Translational Sciences (UL1TR002494), the Biotechnology Research Center (P41 EB015 894), the NINDS Institutional Center Core Grants to Support Neuroscience Research (P30 NS076408), the High Performance Connectome Upgrade for Human 3TMR Scanner (1S10OD017974-01), and the University Foundation, Amplatz Scholarship. The online version of the article has been corrected to reflect this additional information. The authors wish to apologize for the omission.

Original language	English (US)
Pages (from-to)	77
Number of pages	1
Journal	Journal of child and adolescent psychopharmacology
Volume	29
Issue number	1
DOIs	https://doi.org/10.1089/cap.2018.0030.correx
State	Published - 2019

Bibliographical note

Publisher Copyright:
Copyright © 2019 Mary Ann Liebert, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1089/cap.2018.0030.correx

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354592

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)'. Together they form a unique fingerprint.

Cite this

Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Westlund Schreiner, M., Ren, Y., Eberly, L. E., Carstedt, P., Samikoglu, A., Gunlicks-Stoessel, M., Reigstad, K., Horek, N., Tye, S. J., Lim, K. O., & Klimes-Dougan, B. (2019). Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030). Journal of child and adolescent psychopharmacology, 29(1), 77. https://doi.org/10.1089/cap.2018.0030.correx

Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030). / Cullen, K. R.; Amatya, P.; Roback, Mark G et al.
In: Journal of child and adolescent psychopharmacology, Vol. 29, No. 1, 2019, p. 77.

Research output: Contribution to journal › Comment/debate › peer-review

Cullen, KR, Amatya, P, Roback, MG, Albott, CS, Westlund Schreiner, M, Ren, Y, Eberly, LE, Carstedt, P, Samikoglu, A, Gunlicks-Stoessel, M , Reigstad, K, Horek, N, Tye, SJ, Lim, KO & Klimes-Dougan, B 2019, 'Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)', Journal of child and adolescent psychopharmacology, vol. 29, no. 1, pp. 77. https://doi.org/10.1089/cap.2018.0030.correx

Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y et al. Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030). Journal of child and adolescent psychopharmacology. 2019;29(1):77. doi: 10.1089/cap.2018.0030.correx

Cullen, K. R. ; Amatya, P. ; Roback, Mark G et al. / Erratum : Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030). In: Journal of child and adolescent psychopharmacology. 2019 ; Vol. 29, No. 1. pp. 77.

@article{759ef317301043178a69934083ec0d96,

title = "Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)",

abstract = "In the September 2018 issue of Journal of Child and Adolescent Psychopharmacology (vol. 28, no. 7, pp. 437-444), the article {"}Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study,{"} by Dr. Kathryn R. Cullen et al., was missing the financial support information as follows: This research was supported by the National Institutes of Health's National Center for Advancing Translational Sciences (UL1TR002494), the Biotechnology Research Center (P41 EB015 894), the NINDS Institutional Center Core Grants to Support Neuroscience Research (P30 NS076408), the High Performance Connectome Upgrade for Human 3TMR Scanner (1S10OD017974-01), and the University Foundation, Amplatz Scholarship. The online version of the article has been corrected to reflect this additional information. The authors wish to apologize for the omission.",

author = "Cullen, \{K. R.\} and P. Amatya and Roback, \{Mark G\} and Albott, \{C. S.\} and \{Westlund Schreiner\}, M. and Yanan Ren and Eberly, \{L. E.\} and P. Carstedt and A. Samikoglu and M. Gunlicks-Stoessel and K. Reigstad and N. Horek and Tye, \{Susannah J\} and Lim, \{Kelvin O\} and B. Klimes-Dougan",

note = "Publisher Copyright: Copyright {\textcopyright} 2019 Mary Ann Liebert, Inc.",

year = "2019",

doi = "10.1089/cap.2018.0030.correx",

language = "English (US)",

volume = "29",

pages = "77",

journal = "Journal of child and adolescent psychopharmacology",

issn = "1044-5463",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)

AU - Cullen, K. R.

AU - Amatya, P.

AU - Roback, Mark G

AU - Albott, C. S.

AU - Westlund Schreiner, M.

AU - Ren, Yanan

AU - Eberly, L. E.

AU - Carstedt, P.

AU - Samikoglu, A.

AU - Gunlicks-Stoessel, M.

AU - Reigstad, K.

AU - Horek, N.

AU - Tye, Susannah J

AU - Lim, Kelvin O

AU - Klimes-Dougan, B.

PY - 2019

Y1 - 2019

N2 - In the September 2018 issue of Journal of Child and Adolescent Psychopharmacology (vol. 28, no. 7, pp. 437-444), the article "Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study," by Dr. Kathryn R. Cullen et al., was missing the financial support information as follows: This research was supported by the National Institutes of Health's National Center for Advancing Translational Sciences (UL1TR002494), the Biotechnology Research Center (P41 EB015 894), the NINDS Institutional Center Core Grants to Support Neuroscience Research (P30 NS076408), the High Performance Connectome Upgrade for Human 3TMR Scanner (1S10OD017974-01), and the University Foundation, Amplatz Scholarship. The online version of the article has been corrected to reflect this additional information. The authors wish to apologize for the omission.

AB - In the September 2018 issue of Journal of Child and Adolescent Psychopharmacology (vol. 28, no. 7, pp. 437-444), the article "Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study," by Dr. Kathryn R. Cullen et al., was missing the financial support information as follows: This research was supported by the National Institutes of Health's National Center for Advancing Translational Sciences (UL1TR002494), the Biotechnology Research Center (P41 EB015 894), the NINDS Institutional Center Core Grants to Support Neuroscience Research (P30 NS076408), the High Performance Connectome Upgrade for Human 3TMR Scanner (1S10OD017974-01), and the University Foundation, Amplatz Scholarship. The online version of the article has been corrected to reflect this additional information. The authors wish to apologize for the omission.

UR - https://www.scopus.com/pages/publications/85060546962

UR - https://www.scopus.com/pages/publications/85060546962#tab=citedBy

U2 - 10.1089/cap.2018.0030.correx

DO - 10.1089/cap.2018.0030.correx

M3 - Comment/debate

C2 - 30585735

AN - SCOPUS:85060546962

SN - 1044-5463

VL - 29

SP - 77

JO - Journal of child and adolescent psychopharmacology

JF - Journal of child and adolescent psychopharmacology

IS - 1

ER -